Skandinaviska Enskilda Banken (SEB)
MRTX

Skandinaviska Enskilda Banken (SEB)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,200
Closed -$1.3M – 982
2023
Q4 		$1.3M Buy
22,200
+9,061
+69% +$509K 0.01% 655
2023
Q3 		$572K Sell
13,139
-35,214
-73% -$1.26M ﹤0.01% 748
2023
Q2 		$1.75M Sell
48,353
-46,559
-49% -$1.92M 0.01% 584
2023
Q1 		$3.53M Sell
94,912
-583
-0.6% -$26.2K 0.02% 426
2022
Q4 		$4.33M Sell
95,495
-40
-0% -$2.59K 0.03% 376
2022
Q3 		$6.67M Buy
95,535
+40,693
+74% +$3.01M 0.05% 304
2022
Q2 		$3.68M Hold
54,842
– – 0.03% 424
2022
Q1 		$4.51M Sell
54,842
-27
-0% -$2.76K 0.03% 428
2021
Q4 		$8.13M Buy
54,869
+334
+0.6% +$51.9K 0.04% 329
2021
Q3 		$9.65M Sell
54,535
-13,098
-19% -$2.11M 0.05% 294
2021
Q2 		$10.9M Buy
67,633
+58,774
+663% +$9.44M 0.07% 263
2021
Q1 		$1.52M Buy
+8,859
New +$1.75M 0.01% 734

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s MRTX Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 22,200 shares — an estimated $1.3M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MRTX in Q1 2021 and held it in 12 quarters. The position peaked at $10.9M in Q2 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 22,200 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.3M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Mirati Therapeutics, Inc. Common Stock position peaked at $10.9M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.